Capacity Bio

Capacity Bio is a life sciences company in Los Angeles, United States. It has raised $35.0M across 1 round, most recently a $35.0M Series A in March 2023.

The Mitophagy Company

Employees
1–10
Business Model
B2B
Total Funding
$35.0M
Last Round
$35.0M Series AMar 2023
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 3 investors for this company. The full record is or through the API.

About

Capacity Bio is a mitochondria-focused biotechnology company developing first-in-class therapeutics that enhance the body's mitophagy process — the cellular mechanism by which dysfunctional mitochondria are identified, removed, and replaced. The company's proprietary platform uses small molecules, peptides, and nanoparticles to activate mitophagy pathways implicated in aging, neurodegeneration, and metabolic disease. Headquartered in Los Angeles and with a Japanese subsidiary in Tokyo, Capacity Bio closed a $35 million financing round in March 2023 co-led by RA Capital Management and Insight Partners, with participation from existing investor Remiges Ventures. Its lead mitophagy agonist program was advancing toward clinical trials in 2024.

Summary

It lists 1–10 employees. It has raised $35.0M in total across 1 round, most recently a $35.0M Series A round in Mar 2023. Investors include RA Capital Management, Insight Partners and Remiges Ventures.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series ASeries AMar 2023
$35.0M

Investors

Similar Companies

Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
Isomorphic Labs

AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...

London, United Kingdom201–500Artificial Intelligence, Biotech
Series BTotal funding$2.6BMay 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech, Healthcare
Corporate RoundTotal funding$2.3BJun 2018
PHC

PHC is a leading provider of diabetes monitoring systems, specialized laboratory equipment, and c...

Minato, Japan5001–10000Healthcare, Life Sciences
Private EquityTotal funding$1.9BMar 2021

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Capacity Bio on Indexed.vc
<a href="https://indexed.vc/companies/capacity-bio"><img src="https://indexed.vc/api/badge/company/capacity-bio" alt="Capacity Bio on Indexed.vc" width="260" height="76" /></a>